home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Understanding the Process Validation Life Cycle

 
  January 16, 2020  
     
 
CfPA-The Center for Professional Advancement, Online Live
March 31, 2020 at 11:00 a.m.–12:30 p.m. (ET)


Who Should Attend?
This online training will benefit professionals in the following industries: Pharmaceutical, Biotechnology, Medical Device, Chemical Processing, Food, Cosmetics, and Biologics

Potential job functions that would apply include: Engineers, Chemists, Scientists, Formulators, Documentation Specialists, Auditors, Managers, Technicians

In departments such as: Manufacturing, Operations, QA/QC, Engineering

Course Description
This 90-minute, accredited training is intended to help you better understand and get familiar with best practices for Process Validation applicable for the highly regulated biological / pharmaceutical industry. This course is further intended to discuss the life cycle of the Process Validation system. You will learn when a process should be validated, the basic components of a Process Validation (IQ, OQ, and PQ) and how to write protocols and reports.
 
 
Organized by: CfPA-The Center for Professional Advancement
Invited Speakers:
   Danielle DeLucy, MS; Owner, ASA Training & Quality Consulting LLC

D
anielle DeLucy, MS, is currently the owner of ASA Training & Quality Consulting, LLC, an Independent Consultant Agency to the Biologics and Pharmaceutical Industries specializing in the areas of Quality Assurance and Quality Systems. Prior to this role, Ms. DeLucy has been in the industry for 18 years serving in numerous Quality Management Roles, such as the Director of Product Quality, the oversight of Sterility Assurance practices and provided QA oversight of numerous filling and packaging operations. Ms. DeLucy began her QA career as a Quality Control Pharmaceutical Microbiologist at a contract laboratory where she performed various tests for their clients. In the years after, she has held positions in the Quality management arena while increasing her responsibility. She has helped to lead many Regulatory Health Inspections and was instrumental in the coaching process of her peers prior to any inspection. Currently, Ms. DeLucy assists companies who are faced with warning letters and consent decrees establish more robust quality systems so that the company can succeed.
 
Deadline for Abstracts: N/A
 
Registration: Please click here for registration information.
E-mail: Jmorbit@cfpa.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.